About Dr. Nirdosh Jagota
Nirdosh Jagota, PhD, is Vice President of Regulatory Affairs at Ironwood Pharmaceuticals. He is also a part-time assistant professor at the University of Georgia College of Pharmacy and a consultant and managing partner at GRQ Biotech Advisors. His work spans drug development and regulatory review, including the evidence companies submit to show how they manufacture medicines and control their quality.
Industry Experience
Jagota has worked in the pharmaceutical and biotechnology industries for more than 30 years. His experience includes regulatory strategy for small-molecule drugs and biologics, pharmaceutical quality, and changes to manufacturing after a medicine has been approved. Before his work at Ironwood, he held leadership roles at Amgen, Merck, Genentech and Pfizer. At Amgen, he served as Vice President of Global Quality.
- Amgen
- Genentech
- Merck
- Pfizer
Teaching and Education
At the University of Georgia, Jagota teaches regulatory science in the College of Pharmacy’s International Biomedical Regulatory Sciences and Clinical Trials Programs. His faculty appointment is based at UGA Gwinnett in Lawrenceville, Georgia. He draws on industry experience to help students understand how decisions about development and manufacturing affect the evidence submitted for regulatory review.
Jagota earned a PhD in pharmaceutical sciences from the University of Georgia and an MS in pharmaceutical sciences from the University of Toledo. He holds bachelor’s and master’s degrees in pharmacy from the Indian Institute of Technology in Varanasi, India.
- Pharmaceutical sciences and pharmacy
- Graduate study at the University of Georgia and the University of Toledo
- Pharmacy degrees from the Indian Institute of Technology in Varanasi
Publications and Patent
His publications trace that connection from the laboratory to the manufacturing plant. In 1996, publishing as N. K. Jagota, he was the lead author of a study on using ion chromatography to measure two amines in pharmaceuticals. In 2009, he coauthored a Pharmaceutical Technology article on Wyeth’s experience applying Quality by Design in regulatory submissions. In 2015, he coauthored a Journal of Pharmaceutical Sciences paper on regulatory and quality considerations for continuous manufacturing. He is also one of four inventors named on a U.S. patent granted in 2023 for a system that manages changes to regulatory dossiers.
Sources and selected work
- University of Georgia College of Pharmacy faculty profile
- UGA Online faculty biography
- UGA Gwinnett campus
- GRQ Biotech Advisors profile
- Ion chromatography in pharmaceutical analysis (1996)
- Wyeth’s regulatory submissions and Quality by Design (2009)
- Regulatory and quality considerations for continuous manufacturing (2015)
- U.S. Patent 11,545,270 B1 (2023)
Chromatography
Lead author of a 1996 pharmaceutical analysis study
Continuous Manufacturing
Coauthor of a 2015 Journal of Pharmaceutical Sciences paper
U.S. Patent 11,545,270
Co-inventor of a system to manage regulatory dossier changes